Multivariate analyses revealed that a high level of DHHC9 expression and PM-localized GLUT1 was an independent, unfavorable prognostic indicator for OS of GBM patients after adjusting for patient age, sex, and total resection status, all of which are relevant clinical covariates (Supplementary Table 1). This evidence concerns the gene ZDHHC9 and glioblastoma.